Clinical Trial Update: Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial comparing celecoxib with a non-selective NSAID for efficacy and safety in acute ankle sprain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankle Sprain

Drugs mentioned

• Celecoxib (Celecoxib)
• Non-selective NSAID

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Ankle Sprain | Phase 4 | Status: COMPLETED | Results posted: 2009-06-10